Adenosine analogs attenuate tolerance-dependence on alprazolam

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Benzodiazepines like alprazolam are widely prescribed for anxiety and insomnia.
• Understanding the neurobiological mechanisms underlying benzodiazepine tolerance and dependence is crucial for clinical management.

Purpose of the Study:

• To investigate the role of adenosine in the development of alprazolam-induced tolerance and physical dependence in a mouse model.
• To explore potential therapeutic targets for mitigating benzodiazepine withdrawal symptoms.

Main Methods:

• Alprazolam tolerance and physical dependence were established in mice using a slow-release preparation.
• Tolerance was assessed by measuring motor incoordination after a challenge dose of alprazolam.
• Physical dependence was evaluated by observing the severity of the abstinence syndrome precipitated by flumazenil administration.
• The effects of various adenosine receptor agonists and antagonists (L-PIA, CPA, CHA, NECA, 8-PTP, TP) on tolerance and abstinence were examined.

Main Results:

• Administration of L-phenylisopropyl adenosine (L-PIA), cyclopentyl adenosine (CPA), N-ethylcarboxamide adenosine (NECA), 8-phenyltheophylline (8-PTP), and theophylline (TP) reduced the intensity of alprazolam tolerance.
• L-PIA, CPA, NECA, TP, and 8-PTP attenuated the severity of the flumazenil-induced abstinence syndrome.
• These findings indicate that adenosine modulation can impact benzodiazepine tolerance and dependence.

Conclusions:

• Adenosine signaling in the central nervous system plays a significant role in the development of alprazolam tolerance and physical dependence.
• Targeting adenosine pathways may offer novel strategies for managing benzodiazepine dependence and withdrawal symptoms.